China boosts medical insurance spending on innovative drugs
Share - WeChat

BEIJING -- During the 14th Five-Year Plan period (2021-2025), China's medical insurance spending on drugs newly included in the negotiations list, or the innovative drugs, grew significantly, increasing by 40 percent annually, an official from the National Healthcare Security Administration said on Thursday.
In 2024, related spending reached 3.9 times the amount recorded in 2020, Zhang Ke, head of the administration, told a press conference.
During this period, medical insurance fund expenditures totaled 12.13 trillion yuan (about $1.7 trillion), growing at an average annual rate of 9.1 percent, Zhang said.
- China to send new navy fleet for escort missions in Gulf of Aden
- Shandong mobilizes resources to minimize crop losses caused by rain
- China reports significant progress in child welfare provision
- New animation showcases Xinjiang's 70-year development
- Guizhou villagers harvest kiwis in bustling orchards
- Xizang earthquake survivors move into new homes